Amivantamab and Recombinant Human Hyaluronidase/Lazertinib Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of amivantamab and recombinant human hyaluronidase, and lazertinib that may be used in the treatment of non-small cell lung cancer (NSCLC).

**Synonyms:** - Amivantamab and Hyaluronidase-Lazertinib Regimen - Amivantamab and Hyaluronidase-lpuj/Lazertinib Regimen - Amivantamab and Hyaluronidase/Lazertinib Regimen - Amivantamab and Recombinant Human Hyaluronidase/Lazertinib - Amivantamab-Hyaluronidase/Lazertinib - Lazcluze/Rybrevant Faspro - Lazertinib/Amivantamab and Recombinant Human Hyaluronidase - Rybrevant Faspro/Lazcluze Regimen